As the results of new HIV prevention technology (NPT) trials are released and discussions emerge about the implications of the results, it is important that a range of stakeholders understand what the results mean, and the process that led to their discovery. Understanding the research process will help advocates, policy makers and service providers to prepare for the outcomes of prevention trials and communicate about trial results. This fact sheet outlines the basic steps in the research process and the roll‐out of NPTs; where research is taking place and why; the role and experience of study volunteers; and the roles of other players in NPT research.
Publication Categories
Archives(2)
Combination Prevention(26)
Community and Health Systems Strengthening(9)
HIV and Co-infections(4)
Key Populations and Vulnerable Groups(19)
Public Policy and Global Engagement(11)
Reproductive, Maternal, Newborn and Child Health (RMNCH)(1)
Social Determinants of Health(15)
Toolkits(7)
Twinning(6)
Publication
Understanding the Research Process for New HIV Prevention Technologies
Related Content:
Bridging the Gap Between Community and Researchers December 4, 2018 By Jes Hovanes, Communications and Social Media Officer, CIHR Canadian HIV Trials NetworkThere is a line in Tony Kushner’s 1991 play Angels in America where, in the early days of…
Moving Forward from the Canadian Policy Dialogue on TB and HIV: Key Policy and Programming Considerations for the Canadian Response to TB and HIV August 20, 2019 This resource, by ICAD in partnership with Results Canada, is the result of multi-sectoral policy dialogue on TB and HIV which brought together participants from several sectors, working in many…
Recording - The MSAFIRI Post Migration Health Project June 13, 2018 The "Understanding HIV Transmission in African, Caribbean and Black (ACB) Communities Following Arrival in Canada Study" or MSAFIRI project was implemented between 2014 - 2017 with aim of shedding light…
Closing the Gap? Cut the Crap! December 4, 2018 New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention OptionsBy Marc-André LeBlanc, Founding member of IRMA International Rectal Microbicide Advocates (IRMA) and our many partners and…
ICAD Strategic Planning Process August 7, 2020 Dear ICAD Coalition members and partners, We hope that you and your families are doing well despite these turbulent, challenging and unprecedented times. At this moment in history, we find…
Black Praise United: A Call to Serve April 26, 2021 The Black Church, HIV and Health among Black Canadian CommunitiesAn online forum on the role of Black churches in addressing HIV and promoting healthy Black communitiesA free event for participants…